Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.93
The Vanguard Group, Inc. 9.74
Vanguard Group, Inc. (Subfiler) 9.29
State Street Corp. 4.40
BlackRock Fund Advisors 3.15
Vanguard Total Stock Market ETF 3.14
JPMorgan Investment Management, Inc. 3.10
Capital Research & Management Co. (International Investors) 3.02
Vanguard 500 Index Fund 2.47
BlackRock Institutional Trust Co. NA 2.30
Geode Capital Management LLC 1.95
Norges Bank (13F) 1.49
Government Pension Fund - Global (The) 1.25
SPDR S&P 500 ETF Trust 1.19
Fidelity 500 Index Fund 1.18

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 30’000 30’250 32’200 34’300 34’100
Umsatz pro Mitarbeiter in Mio. EUR 0.87 1.41 1.44 1.35 1.32

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 29’354 30’192 33’262 27’273 31’770
Summe Anlagevermögen 99’136 89’495 81’542 71’778 70’894
Summe Aktiva 129’944 118’481 109’314 96’820 95’159

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 47’538 51’673 45’596 40’717 41’464
Summe Fremdkapital 78’246 80’599 73’308 65’702 65’674
Summe Eigenkapital 51’698 37’882 36’006 31’118 29’485
Summe Passiva 129’944 118’481 109’314 96’820 95’159

Adresse

Route 206 & Province Line Road, 08543 Princeton
Telefon +1 (609) 252-4621
URL http://www.bms.com

Management

Abed Al-Nasser Odeh
Manager
Adam Lenkowsky
Chief Commercialization Officer & Executive VP
Amanda Poole
Chief Human Resources Officer & Executive VP
Cari Gallman
Executive Vice President-Corporate Affairs
Catalina Vargas
Chief Of Staff
Christopher S. Boerner
Chief Executive Officer & Director
Cynthia Piccirillo
Group Director
David V. Elkins
Chief Financial Officer & Executive Vice President
Deepak L. Bhatt
Independent Director
Derica W. Rice
Independent Director
Elizabeth Mily
Executive VP-Strategy & Business Development
Estelle Vester-Blokland
Senior VP-Global Medical Affairs
Frank Incontrera
Director-Global Energy Services
Gerald L. Storch
Independent Director
Giovanni Caforio
Executive Chairman
Greg Meyers
Chief Digital & Technology Officer
Julia A. Haller
Independent Director
Karen H. Vousden
Independent Director
Kimberly McCutcheon Jablonski
Secretary, Chief Compliance & Ethics Officer
Krisztina Nemenyi
Head-Asia Pacific Global Regulatory Affairs
Laura Hortas
Head-Corporate & Employee Communications
Louis S. Schmukler
President-Global Product Development & Supply
MARIA V LOPEZ BRESNAHAN
Vice President
Manuel Hidalgo Medina
Independent Director
Mark Rolfe
Senior Vice President
Michelle Weese
Executive Vice President-Corporate Affairs
Monica Shaw
Senior Vice President-Major Markets
Paula A. Price
Independent Director
Peter J. Arduini
Independent Director
Phil Holzer
Senior Vice President & Controller
Phyllis R. Yale
Independent Director
Robert M. Plenge
Chief Research Officer, Head-Research & EVP
Samit Hirawat
Chief Medical Officer & EVP-Drug Development
Sandra Leung
Executive Vice President & General Counsel
Teresa M. Foy
Senior VP-Immuno Oncology & Cell Therapy
Theodore Rapp Samuels
Lead Independent Director
William Perhacs
Director-Global Energy & Sustainability Services
Zack Newman
Associate Director-Global Sustainability Strategy

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen